The dynamic landscape of liver transplant in the era of effective hepatitis C virus therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

1. Mortality and Morbidity Among Adult Liver Retransplant Recipients.Digestive diseases and sciences · 2023
   Article
2. Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment.Life (Basel, Switzerland) · 2023
   Review
3. Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Viruses · 2022
   Observational
4. Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis.Journal of the Chinese Medical Association : JCMA · 2022
   Article
5. From hepatitis A to E: A critical review of viral hepatitis.World journal of gastroenterology · 2021
   Review
6. Hepatitis C virus therapy in advanced liver disease: Outcomes and challenges.United European gastroenterology journal · 2019
   Review
7. Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate.Current gastroenterology reports · 2018
   Review
8. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.World journal of gastroenterology · 2018
   Review
9. Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.Journal of clinical and translational hepatology · 2017
   Review
10. HCV treatment in patients with decompensated liver disease.Clinical liver disease · 2017
    Review

Corrections and comments

• Comment on
  G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.2017

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as